As a part of the government’s third batch of vaccination program for children, Yayasan Pendidikan Pelita Harapan (YPPH) held COVID-19 vaccination drive for Sekolah Pelita Harapan (SPH) students aged 12-17 on Sunday, July 4, 2021, at their main campus in Tangerang, Lippo Village. SPH is the first school in Jabodetabek to receive COVID-19 vaccination for students.
This vaccination is offered to all SPH students across 5 campuses: SPH Lippo Village, Sentul City, Lippo Cikarang, Kemang Village, and Pluit Village. Aside from vaccinating its students, SPH also ran vaccination drives for parents from July 2 to 4, 2021.
“The health and safety of our school community remain a top priority for the Pelita Harapan Education Foundation. Vaccination is a key component of school reopening in the coming months. When students are vaccinated, we can protect families as well as our teachers and staff. For this first stage, we are providing 600 doses of vaccine for Sekolah Pelita Harapan and Dian Harapan students,” said Stephanie Riady, Executive Director of YPPH.
This vaccination program is a crucial step taken by SPH to prepare for onsite learning in the 2021/2022 Academic Year which will start in early August. SPH prioritizes the safety and health for all students and its surrounding community, and this vaccination is expected to make face-to-face learning safer for everyone.
“We are grateful that the Indonesian government is working efficiently to quicken vaccinations for everyone. This program is vital in safeguarding our community and essential in our school reopening plans in the month of August. We expect most of our community to be vaccinated so that learning can once again resume without any disruption,” said Emilia Djohan, Director of Administration.
Based on Surat Edaran (Circular Letter) no. HK.02.02/I/1727/2021 from the Ministry of Health of the Republic of Indonesia, vaccination for children needs to be prioritized immediately. COVID-19 vaccination for children has been declared safe with the recommendation from the Indonesian Technical Advisory Group on Immunization (ITAGI) and the BPOM’s approval for the use of Sinovac vaccine for the 12–17-year age group as per 27 June 2021.
Learn more about SPH: https://sph.edu/